BACKGROUND: The aim of this study was to assess the prognostic value of technetium-99m tetrofosmin gated SPECT imaging in women using quantitative gated single photon emission computed tomography (SPECT) imaging. METHODS: We followed 453 consecutive female patients. Average follow-up was 1.33 years (max. 2.55). Hard endpoints were cardiac death, acute myocardial infarction, or documented ventricular fibrillation. Event-free survival curves were obtained. Optimal cutoff values for left ventricular (LV) volumes, LV ejection fraction (LVEF), and perfusion data to predict outcome were determined by ROC curve analysis. RESULTS: A total of 236 patients had an abnormal study, of whom 27 patients experienced hard events (16 deaths) and 47 patients soft events. For hard events summed stress score (SSS) and LVEF, and for any cardiac event SSS showed independent incremental prognostic value. The survival curves were maximally separated when using cutoff values for SSS of > or = 22 and LVEF < 52% (P < 0.001, HR 4.61 and P < 0.001 HR 5.24 for SSS and LVEF resp.), and SSS > or = 14 (P < 0.001 HR 3.76) for any cardiac event. CONCLUSION: In women, perfusion and functional parameters derived from quantitative gated technetium-99m tetrofosmin SPECT imaging can adequately be used for cardiac risk assessment. Using quantitative gated SPECT, female patients with an LVEF < 52% or an SSS > or = 22 are at increased risk for subsequent hard events. Furthermore, patients with an SSS > or = 14 are at increased risk for any cardiac events.
BACKGROUND: The aim of this study was to assess the prognostic value of technetium-99m tetrofosmin gated SPECT imaging in women using quantitative gated single photon emission computed tomography (SPECT) imaging. METHODS: We followed 453 consecutive female patients. Average follow-up was 1.33 years (max. 2.55). Hard endpoints were cardiac death, acute myocardial infarction, or documented ventricular fibrillation. Event-free survival curves were obtained. Optimal cutoff values for left ventricular (LV) volumes, LV ejection fraction (LVEF), and perfusion data to predict outcome were determined by ROC curve analysis. RESULTS: A total of 236 patients had an abnormal study, of whom 27 patients experienced hard events (16 deaths) and 47 patients soft events. For hard events summed stress score (SSS) and LVEF, and for any cardiac event SSS showed independent incremental prognostic value. The survival curves were maximally separated when using cutoff values for SSS of > or = 22 and LVEF < 52% (P < 0.001, HR 4.61 and P < 0.001 HR 5.24 for SSS and LVEF resp.), and SSS > or = 14 (P < 0.001 HR 3.76) for any cardiac event. CONCLUSION: In women, perfusion and functional parameters derived from quantitative gated technetium-99m tetrofosmin SPECT imaging can adequately be used for cardiac risk assessment. Using quantitative gated SPECT, female patients with an LVEF < 52% or an SSS > or = 22 are at increased risk for subsequent hard events. Furthermore, patients with an SSS > or = 14 are at increased risk for any cardiac events.
Authors: O De Winter; N Van De Veire; P De Bondt; C Van De Wiele; M De Buyzere; G De Backer; T C Gillebert; R A Dierckx; J De Sutter Journal: Q J Nucl Med Mol Imaging Date: 2007-01-15 Impact factor: 2.346
Authors: Yves G C J America; Jeroen J Bax; Petra Dibbets-Schneider; Ernest K J Pauwels; Ernst E Van der Wall Journal: Int J Cardiovasc Imaging Date: 2005-10 Impact factor: 2.357
Authors: T Sharir; G Germano; X Kang; H C Lewin; R Miranda; I Cohen; R D Agafitei; J D Friedman; D S Berman Journal: J Nucl Med Date: 2001-06 Impact factor: 10.057
Authors: Jennifer H Mieres; Leslee J Shaw; Andrew Arai; Matthew J Budoff; Scott D Flamm; W Gregory Hundley; Thomas H Marwick; Lori Mosca; Ayan R Patel; Miguel A Quinones; Rita F Redberg; Kathryn A Taubert; Allen J Taylor; Gregory S Thomas; Nanette K Wenger Journal: Circulation Date: 2005-02-01 Impact factor: 29.690
Authors: V M Gil; M Almeida; A Ventosa; J Ferreira; C Aguiar; J Calqueiro; R Seabra-Gomes Journal: J Nucl Cardiol Date: 1998 Jul-Aug Impact factor: 5.952
Authors: D S Berman; X Kang; K F Van Train; H C Lewin; I Cohen; J Areeda; J D Friedman; G Germano; L J Shaw; R Hachamovitch Journal: J Am Coll Cardiol Date: 1998-12 Impact factor: 24.094
Authors: Jennifer H Mieres; Leslee J Shaw; Robert C Hendel; D Douglas Miller; Robert O Bonow; Daniel S Berman; Gary V Heller; Jennifer H Mieres; C Noel Bairey-Merz; Daniel S Berman; Robert O Bonow; Jean M Cacciabaudo; Gary V Heller; Robert C Hendel; Maria C Kiess; D Douglas Miller; Donna M Polk; Leslee J Shaw; Paola E Smanio; Mary N Walsh Journal: J Nucl Cardiol Date: 2003 Jan-Feb Impact factor: 5.952
Authors: Otavio R Coelho-Filho; Luciana F Seabra; François-Pierre Mongeon; Shuaib M Abdullah; Sanjeev A Francis; Ron Blankstein; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong Journal: JACC Cardiovasc Imaging Date: 2011-08